Pinkert J - Search Results

1

[Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan. Clinical considerations, radiopharmacy, radiation protection, perspectives].

Schomäcker K, Dietlein M, Schnell R, Pinkert J, Eschner W, Zimmermanns B, Fischer T, Engert A, Schicha H. Schomäcker K, et al. Among authors: pinkert j. Nuklearmedizin. 2005;44(4):166-77. doi: 10.1267/nukl05040166. Nuklearmedizin. 2005. PMID: 16163413 German.

2

Retrospective web-based multicenter evaluation of ¹⁸F-FDG-PET and CT derived predictive factors. Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan in follicular non Hodgkin's lymphoma.

Grgic A, Nestle U, Scheidhauer K, Puskas C, Ballek E, Hohloch K, Schubert J, König J, Pinkert J, Truemper L, Hellwig D, Kirsch CM. Grgic A, et al. Among authors: pinkert j. Nuklearmedizin. 2011;50(1):39-47. doi: 10.3413/nukmed-0322-10-06. Epub 2010 Nov 8. Nuklearmedizin. 2011. PMID: 21057722

3

[Can immunoradiometric measurement of thyrotropin (TSH) in human serum compete with a luminometric assay?].

Zöphel K, Pinkert J, Wunderlich G, Grüning T, Franke WG. Zöphel K, et al. Among authors: pinkert j. Nuklearmedizin. 1999;38(5):150-5. Nuklearmedizin. 1999. PMID: 10488482 German.

4

Pre- and intratherapeutical ibritumomab tiuxetan Zevalin® dosimetry in childhood.

Happel C, Diener J, Kranert WT, Bockisch B, Pinkert J, Grünwald F. Happel C, et al. Among authors: pinkert j. Nuklearmedizin. 2013;52(5):N58-9. Nuklearmedizin. 2013. PMID: 24085461 No abstract available.

5

Physical aspects of scintigraphy-based dosimetry for nuclear medicine therapy.

Geworski L, Schaefer A, Knoop BO, Pinkert J, Plotkin M, Kirsch CM. Geworski L, et al. Among authors: pinkert j. Nuklearmedizin. 2010;49(3):85-95. doi: 10.3413/nukmed-0283. Nuklearmedizin. 2010. PMID: 20505893

6

Accuracy of the intra-operative radioguided localization of the sentinel lymph node (SLN) 24 hours after lymphoscintigraphy in patients with malignant melanoma.

Kropp J, Stein A, Hackert I, Sebastian G, Meurer M, Grüning T, Liepe K, Pinkert J, Franke WG. Kropp J, et al. Among authors: pinkert j. Nuklearmedizin. 2001 Jun;40(3):86-90. Nuklearmedizin. 2001. PMID: 11475078

7

Combining 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: first experience.

Suttmann H, Grgic A, Lehmann J, Zwergel U, Kamradt J, Gouverneur E, Pinkert J, Stöckle M, Kirsch CM, Nestle U. Suttmann H, et al. Among authors: pinkert j. Cancer Biother Radiopharm. 2008 Oct;23(5):609-18. doi: 10.1089/cbr.2008.0487. Cancer Biother Radiopharm. 2008. PMID: 18999933

8

Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas?

Franke WG, Pinkert J, Runge R, Bredow J, Wunderlich G, Koch R. Franke WG, et al. Among authors: pinkert j. Anticancer Res. 2000 Nov-Dec;20(6D):5257-60. Anticancer Res. 2000. PMID: 11326706

9

Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy.

Wunderlich G, Pinkert J, Andreeff M, Stintz M, Knapp FF Jr, Kropp J, Franke WG. Wunderlich G, et al. Among authors: pinkert j. Appl Radiat Isot. 2000 Jan;52(1):63-8. doi: 10.1016/s0969-8043(99)00093-7. Appl Radiat Isot. 2000. PMID: 10670924

10

[Changes in regional cerebral perfusion in depression.SPECT monitoring of response to treatment].

Holthoff VA, Beuthien-Baumann B, Pietrzyk U, Pinkert J, Oehme L, Franke WG, Bach O. Holthoff VA, et al. Among authors: pinkert j. Nervenarzt. 1999 Jul;70(7):620-6. doi: 10.1007/s001150050487. Nervenarzt. 1999. PMID: 10434261 Clinical Trial. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters